In Brief This Week: Cepheid; BD; Transgenomic; Synthetic Genomics; Genetic Technologies; BioTime; Kiyatec; ABL
May 25, 2012
In Brief This Week: Cepheid; BD; Transgenomic; Synthetic Genomics; Genetic Technologies; BioTime; Kiyatec; ABL
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - In Brief This Week: NanoString; Genedata, Leco; Transgenomic; BioTime; Waters; ACMG, NBSTRN
September 28, 2012 / GenomeWeb Daily News - MDx/CDx Focus: Cepheid Updates BCR-ABL Test; Medicare Covers Transgenomic Plavix Dx; Lungevity Awards
July 25, 2012 / Pharmacogenomics Reporter - Dx Focus: Cepheid GeneXpert Infinity-80 and Xpert Flu, CT/NG, and CT; Transgenomic KRAS Assay
May 24, 2012 / PCR Insider